1. Home
  2. GFAI vs CLGN Comparison

GFAI vs CLGN Comparison

Compare GFAI & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

N/A

Current Price

$0.17

Market Cap

5.5M

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

N/A

Current Price

$3.85

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GFAI
CLGN
Founded
2018
2004
Country
Singapore
Israel
Employees
1657
N/A
Industry
Diversified Commercial Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.2M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
GFAI
CLGN
Price
$0.17
$3.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 200.9K
49.9K
Earning Date
09-23-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.88
N/A
Revenue Next Year
$5.00
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.26
52 Week High
$0.98
$4.78

Technical Indicators

Market Signals
Indicator
GFAI
CLGN
Relative Strength Index (RSI) 27.97 55.59
Support Level N/A $0.34
Resistance Level $0.41 $4.64
Average True Range (ATR) 0.02 0.36
MACD 0.00 -0.03
Stochastic Oscillator 5.95 49.61

Price Performance

Historical Comparison
GFAI
CLGN

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: